Cysteine oxidation by the postischemic rat kidney

R. C. Scaduto, L. W. Grotyohann

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Renal levels of glutathione are markedly decreased during periods of renal ischemia due to catabolism to cysteine. We previously demonstrated that cysteine accumulates in the tissue as the thiol during ischemia, and resumption of blood flow causes a transient elevation of cysteine levels in the renal venous effluent and return of tissue cysteine levels to control values. In this study, the oxidation state of renal venous cyst(e)ine was determined. Although cysteine accumulated as the reduced thiol during ischemia, cysteine released into the renal vein upon blood reflow was found to be almost entirely in the disulfide form. To distinguish between oxidation of arterial cysteine and renal cysteine formed from ischemia-induced reduced glutathione (GSH) catabolism, a labeling procedure was developed to label kidney GSH with 35S without significant labeling of arterial plasma cyst(e)ine. With this procedure, the source of oxidized cysteine that appeared in the renal venous plasma after ischemia was identified as resulting from renal GSH catabolism. The data indicate that a rapid oxidative process occurs during the initial period of blood reflow to the postischemic kidney. After 35 min of ischemia, 3 μmol cysteine/g dry wt were released from the kidney and oxidized. Cysteine oxidation is also expected to generate oxygen-centered free radicals. Pretreatment of animals with deferoxamine, a iron chelator, was without effect on the relative amount of venous cysteine in the oxidized form, arguing against a role for free iron in this oxidative process. In control animals given cysteine, the redox status of plasma cyst(e)ine remained stable, suggesting that the renal oxidation of cysteine is a unique feature of the postischemic kidney. We conclude that cysteine oxidation occurs in the postischemic kidney and that this could function as a source of free radicals during the initial period of blood reflow.

Original languageEnglish (US)
Pages (from-to)F777-F783
JournalAmerican Journal of Physiology - Renal Fluid and Electrolyte Physiology
Volume262
Issue number5 31-5
StatePublished - Jan 1 1992

Fingerprint

Cysteine
Kidney
Ischemia
Cysts
Sulfhydryl Compounds
Free Radicals
Glutathione
Iron
Renal Veins
Deferoxamine
Chelating Agents
Disulfides
Oxidation-Reduction
Oxygen

All Science Journal Classification (ASJC) codes

  • Physiology

Cite this

Scaduto, R. C. ; Grotyohann, L. W. / Cysteine oxidation by the postischemic rat kidney. In: American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 1992 ; Vol. 262, No. 5 31-5. pp. F777-F783.
@article{9a90fdec45e74d368c0a138e0ab09a80,
title = "Cysteine oxidation by the postischemic rat kidney",
abstract = "Renal levels of glutathione are markedly decreased during periods of renal ischemia due to catabolism to cysteine. We previously demonstrated that cysteine accumulates in the tissue as the thiol during ischemia, and resumption of blood flow causes a transient elevation of cysteine levels in the renal venous effluent and return of tissue cysteine levels to control values. In this study, the oxidation state of renal venous cyst(e)ine was determined. Although cysteine accumulated as the reduced thiol during ischemia, cysteine released into the renal vein upon blood reflow was found to be almost entirely in the disulfide form. To distinguish between oxidation of arterial cysteine and renal cysteine formed from ischemia-induced reduced glutathione (GSH) catabolism, a labeling procedure was developed to label kidney GSH with 35S without significant labeling of arterial plasma cyst(e)ine. With this procedure, the source of oxidized cysteine that appeared in the renal venous plasma after ischemia was identified as resulting from renal GSH catabolism. The data indicate that a rapid oxidative process occurs during the initial period of blood reflow to the postischemic kidney. After 35 min of ischemia, 3 μmol cysteine/g dry wt were released from the kidney and oxidized. Cysteine oxidation is also expected to generate oxygen-centered free radicals. Pretreatment of animals with deferoxamine, a iron chelator, was without effect on the relative amount of venous cysteine in the oxidized form, arguing against a role for free iron in this oxidative process. In control animals given cysteine, the redox status of plasma cyst(e)ine remained stable, suggesting that the renal oxidation of cysteine is a unique feature of the postischemic kidney. We conclude that cysteine oxidation occurs in the postischemic kidney and that this could function as a source of free radicals during the initial period of blood reflow.",
author = "Scaduto, {R. C.} and Grotyohann, {L. W.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "262",
pages = "F777--F783",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "5 31-5",

}

Cysteine oxidation by the postischemic rat kidney. / Scaduto, R. C.; Grotyohann, L. W.

In: American Journal of Physiology - Renal Fluid and Electrolyte Physiology, Vol. 262, No. 5 31-5, 01.01.1992, p. F777-F783.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cysteine oxidation by the postischemic rat kidney

AU - Scaduto, R. C.

AU - Grotyohann, L. W.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Renal levels of glutathione are markedly decreased during periods of renal ischemia due to catabolism to cysteine. We previously demonstrated that cysteine accumulates in the tissue as the thiol during ischemia, and resumption of blood flow causes a transient elevation of cysteine levels in the renal venous effluent and return of tissue cysteine levels to control values. In this study, the oxidation state of renal venous cyst(e)ine was determined. Although cysteine accumulated as the reduced thiol during ischemia, cysteine released into the renal vein upon blood reflow was found to be almost entirely in the disulfide form. To distinguish between oxidation of arterial cysteine and renal cysteine formed from ischemia-induced reduced glutathione (GSH) catabolism, a labeling procedure was developed to label kidney GSH with 35S without significant labeling of arterial plasma cyst(e)ine. With this procedure, the source of oxidized cysteine that appeared in the renal venous plasma after ischemia was identified as resulting from renal GSH catabolism. The data indicate that a rapid oxidative process occurs during the initial period of blood reflow to the postischemic kidney. After 35 min of ischemia, 3 μmol cysteine/g dry wt were released from the kidney and oxidized. Cysteine oxidation is also expected to generate oxygen-centered free radicals. Pretreatment of animals with deferoxamine, a iron chelator, was without effect on the relative amount of venous cysteine in the oxidized form, arguing against a role for free iron in this oxidative process. In control animals given cysteine, the redox status of plasma cyst(e)ine remained stable, suggesting that the renal oxidation of cysteine is a unique feature of the postischemic kidney. We conclude that cysteine oxidation occurs in the postischemic kidney and that this could function as a source of free radicals during the initial period of blood reflow.

AB - Renal levels of glutathione are markedly decreased during periods of renal ischemia due to catabolism to cysteine. We previously demonstrated that cysteine accumulates in the tissue as the thiol during ischemia, and resumption of blood flow causes a transient elevation of cysteine levels in the renal venous effluent and return of tissue cysteine levels to control values. In this study, the oxidation state of renal venous cyst(e)ine was determined. Although cysteine accumulated as the reduced thiol during ischemia, cysteine released into the renal vein upon blood reflow was found to be almost entirely in the disulfide form. To distinguish between oxidation of arterial cysteine and renal cysteine formed from ischemia-induced reduced glutathione (GSH) catabolism, a labeling procedure was developed to label kidney GSH with 35S without significant labeling of arterial plasma cyst(e)ine. With this procedure, the source of oxidized cysteine that appeared in the renal venous plasma after ischemia was identified as resulting from renal GSH catabolism. The data indicate that a rapid oxidative process occurs during the initial period of blood reflow to the postischemic kidney. After 35 min of ischemia, 3 μmol cysteine/g dry wt were released from the kidney and oxidized. Cysteine oxidation is also expected to generate oxygen-centered free radicals. Pretreatment of animals with deferoxamine, a iron chelator, was without effect on the relative amount of venous cysteine in the oxidized form, arguing against a role for free iron in this oxidative process. In control animals given cysteine, the redox status of plasma cyst(e)ine remained stable, suggesting that the renal oxidation of cysteine is a unique feature of the postischemic kidney. We conclude that cysteine oxidation occurs in the postischemic kidney and that this could function as a source of free radicals during the initial period of blood reflow.

UR - http://www.scopus.com/inward/record.url?scp=0026741602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026741602&partnerID=8YFLogxK

M3 - Article

C2 - 1590423

AN - SCOPUS:0026741602

VL - 262

SP - F777-F783

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 0363-6127

IS - 5 31-5

ER -